dorfmanmaster

Biotech Double Bottom (+ Divergence & Bollinger Reversal)

Long
dorfmanmaster Updated   
NASDAQ:IBB   iShares Biotechnology ETF
Technical Analysis
1. As you see in the chart, we have tested the 200ema 3 times in the past; and it has not trade below it since April 2020.
We have made a spinning-bottom on a downtrend, coincidental with a 4th test of the 200ema.

2. RSI and OBV show a positive divergence as the bottom from 2 weeks ago (Test #3) was at a lower level.

3. Bollinger Bands give us another bullish signal, as the first low (Test #3) was outside the lower BB, and the second low (Test #4) was inside the lower BB.

Trade Setup
A break below Test #3 which is $142.47 could be a potentially good place to set a stop-loss exit.
Short-term target to the upside --> $160.5
Mid-term target to the upside --> $170


Trade with care
Comment:
Looks like a successful test of the 200ema.
50sma is the next resistance around $159.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.